These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7723410)

  • 1. bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.
    Lepelley P; Soenen V; Preudhomme C; Merlat A; Cosson A; Fenaux P
    Leukemia; 1995 Apr; 9(4):726-30. PubMed ID: 7723410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
    Preudhomme C; Lepelley P; Vachee A; Soenen V; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1993 Nov; 7(11):1888-90. PubMed ID: 7901457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.
    Lepelley P; Soenen V; Preudhomme C; Lai JL; Cosson A; Fenaux P
    Leukemia; 1994 Jun; 8(6):998-1004. PubMed ID: 7516032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
    Brynes RK; Wilson CS; Kim AB; McCourty A
    Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
    Sahu GR; Das BR
    Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
    Boudard D; Vasselon C; Berthéas MF; Jaubert J; Mounier C; Reynaud J; Viallet A; Chautard S; Guyotat D; Campos L
    Am J Hematol; 2002 Jun; 70(2):115-25. PubMed ID: 12111784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.
    Wattel E; Preudhomme C; Hecquet B; Vanrumbeke M; Quesnel B; Dervite I; Morel P; Fenaux P
    Blood; 1994 Nov; 84(9):3148-57. PubMed ID: 7949187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.
    Preudhomme C; Lubin R; Lepelley P; Vanrumbeke M; Fenaux P
    Leukemia; 1994 Sep; 8(9):1589-91. PubMed ID: 8090036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
    Lepelley P; Poulain S; Grardel N; Preudhomme C; Cosson A; Fenaux P
    Leuk Lymphoma; 1998 May; 29(5-6):547-51. PubMed ID: 9643568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of apoptosis regulatory genes expression in the bone marrow (BM) of adult de novo myelodysplastic syndromes (MDS).
    Economopoulou C; Pappa V; Kontsioti F; Papageorgiou S; Kapsimali V; Papasteriadi C; Economopoulou P; Papageorgiou E; Dervenoulas J; Economopoulos T
    Leuk Res; 2008 Jan; 32(1):61-9. PubMed ID: 17597205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does apoptosis have to do with clinical features in myelodysplastic syndrome?
    Ramos F; Fuertes-Núñez M; Suárez-Vilela D; Fernández-López A
    Haematologica; 2002 Apr; 87(4):381-91. PubMed ID: 11940482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.